NCT07148050
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07148050
Title Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells (IMPACT)
Acronym IMPACT
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.